₹707
▲ +6.38 +0.91%
As of 27 Jul 2026 · delayed
NSE Listed
Medplus Health Services Ltd. (MEDPLUS)
Volume: 2,90,078Avg Vol 1W: 8,19,710.8Avg Vol 1M: 2,61,50052W Range:₹653₹1,022.2
Key Ratios
Checked 1d agoMarket Cap₹8,651 Cr
Current Price₹707
Previous Close₹700.62
High / Low (52w)₹1,022.2 / ₹653
Volume2,90,078
Avg Vol (1W)8,19,710.8
Avg Vol (1M)2,61,500
Stock P/E60.47
Book Value₹145.42
Dividend Yield—
ROE9.1%
ROA—
Revenue (TTM)₹6,185 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹2
EPS (TTM)₹12.55
P/B5.22
Debt / Equity0.64
50 DMA₹830.99
200 DMA₹828.54
Day change+0.91%
Price Chart
₹707▼ 22.40% · 1Y
2025-07-292026-07-27
20-day avg volume: 2.6L shares
Pros
- Company is almost debt-free.
Cons
- Stock trades at a high P/E of 60.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,576 Cr | ₹1,561 Cr | ₹1,510 Cr | ₹1,543 Cr | ₹1,679 Cr | ₹1,806 Cr | ₹1,864 Cr | ₹1,880 Cr |
| EBITDA | ₹73 Cr | ₹83 Cr | ₹88 Cr | ₹80 Cr | ₹98 Cr | ₹104 Cr | ₹114 Cr | ₹75 Cr |
| Net Profit | ₹39 Cr | ₹46 Cr | ₹51 Cr | ₹42 Cr | ₹56 Cr | ₹58 Cr | ₹64 Cr | ₹33 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹177 Cr | ₹202 Cr | ₹6,185 Cr | ₹184 Cr | ₹206 Cr | ₹223 Cr | ₹248 Cr | ₹223 Cr |
| EBITDA | ₹14 Cr | ₹20 Cr | ₹286 Cr | ₹20 Cr | ₹23 Cr | ₹24 Cr | ₹24 Cr | ₹25 Cr |
| Net Profit | ₹9 Cr | ₹14 Cr | ₹150 Cr | ₹14 Cr | ₹16 Cr | ₹17 Cr | ₹17 Cr | ₹17 Cr |
| EPS | — | — | 12.52 | — | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹644 Cr | ₹673 Cr | ₹1,349 Cr | ₹1,566 Cr | ₹2,594 Cr | ₹2,797 Cr | ₹3,005 Cr | ₹3,360 Cr |
| Total Liabilities | ₹341 Cr | ₹348 Cr | ₹820 Cr | ₹835 Cr | ₹1,177 Cr | ₹1,306 Cr | ₹1,427 Cr | ₹1,620 Cr |
| Equity | ₹303 Cr | ₹325 Cr | ₹529 Cr | ₹731 Cr | ₹1,417 Cr | ₹1,491 Cr | ₹1,577 Cr | ₹1,740 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹56 Cr | ₹95 Cr | ₹8 Cr | ₹32 Cr | ₹203 Cr | ₹104 Cr | ₹173 Cr | ₹586 Cr |
| Investing | ₹-18 Cr | ₹-20 Cr | ₹-28 Cr | ₹-35 Cr | ₹-703 Cr | ₹429 Cr | ₹-83 Cr | ₹-318 Cr |
| Financing | ₹-1 Cr | ₹-72 Cr | ₹90 Cr | ₹-6 Cr | ₹440 Cr | ₹-170 Cr | ₹-198 Cr | ₹-228 Cr |
| Free Cash Flow | ₹56 Cr | ₹95 Cr | ₹8 Cr | ₹32 Cr | ₹203 Cr | ₹104 Cr | ₹173 Cr | ₹586 Cr |
Shareholding
Promoter 40.19% Institutions 44.33% Public 15.48%
Efficiency & Working Capital
ROCE4.3%
Interest Coverage3.3
Dividend Payout—
Debtor Days1 d
Inventory Days80 d
Payable Days18 d
Cash Conversion Cycle63 d
Working Capital Days81 d
Shareholding Details
As of 2026-06-30
Promoter40.2%
FII14.4%
DII29.9%
Institutions44.3%
Public15.5%
Promoter Pledge60.7%
No. of Shareholders76,005
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 40.4% | 40.5% | 40.4% | 40.4% | 40.4% | 40.4% | 40.3% | 40.3% | 40.3% | 40.3% | 40.2% | 40.2% |
| FIIs | 12.4% | 13% | 14.9% | 14.9% | 14.7% | 15.2% | 15.6% | 16.4% | 16.5% | 16.8% | 15.5% | 14.4% |
| DIIs | 25.5% | 16.3% | 22.5% | 22.2% | 28% | 25.6% | 26.2% | 26% | 26.5% | 26.6% | 27.8% | 29.9% |
| Public | 21.7% | 30.3% | 22.2% | 22.6% | 16.9% | 18.7% | 17.9% | 17.2% | 16.7% | 16.3% | 16.4% | 15.5% |
| Promoter Pledge | 50.5% | 58.1% | 54.2% | 54.2% | 54.2% | 55.2% | 59.3% | 59.3% | 59.3% | 60.7% | 60.7% | 60.7% |
| No. of Shareholders | 66,430 | 66,048 | 74,976 | 76,934 | 87,328 | 83,912 | 83,439 | 81,742 | 78,337 | 79,157 | 77,278 | 76,005 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Lone Furrow Investments Private Limited | Shareholding of Promoter and Promoter Group | 14.4% | 1.73 Cr |
| Agilemed Investments Private Limited | Shareholding of Promoter and Promoter Group | 13% | 1.56 Cr |
| Madhukar Reddy Gangadi | Shareholding of Promoter and Promoter Group | 12.8% | 1.54 Cr |
| Nippon Life India Trustee Ltd-a/c Nippon India Pha | Public Shareholding | 7.3% | 87,89,314 |
| Icici Prudential Pharma Healthcare And Diaganostic | Public Shareholding | 4.9% | 59,18,803 |
| Franklin India Flexi Cap Fund | Public Shareholding | 3.9% | 46,85,864 |
| Sbi Elss Tax Saver Fund | Public Shareholding | 3.4% | 40,67,968 |
| Kotak Small Cap Fund | Public Shareholding | 3.3% | 39,72,222 |
| Fidelity Funds - India Focus Fund | Public Shareholding | 1.7% | 20,19,005 |
| Kuwait Investment Authority Fund 227 | Public Shareholding | 1.6% | 18,66,972 |
| Pravesa Holding Private Limited | Public Shareholding | 1.5% | 18,11,305 |
| Hdfc Life Insurance Company Limited | Public Shareholding | 1.2% | 14,68,623 |
| Bajaj Life Insurance Limited | Public Shareholding | 1% | 12,38,431 |
| Gangadi Investments Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Hinshitsu Manufacturing Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Madhukar Gangadi Ventures Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Foundation For Research And Innovation In Policy | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Agilepro India Venture Llp | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Renuka Gangadi | Shareholding of Promoter and Promoter Group | 0% | 162 |
| Gangadi Veera Reddy | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Gangadi Sugunamma | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Varin Nair | Shareholding of Promoter and Promoter Group | 0% | 0 |
| G Narsimha Reddy | Shareholding of Promoter and Promoter Group | 0% | 2 |
| Rajitha Koppula Reddy | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Inder Mohan Aggarwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Madhukar Reddy Gangadi | 1.54 Cr | 100% | 2026-06-30 |
| Lone Furrow Investments Private Limited | 25,00,000 | 14.5% | 2026-06-30 |
| Agilemed Investments Private Limited | 1.15 Cr | 73.3% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| GANGADI MADHUKAR REDDY | Chairman, MD & CEO | 2025 |
| CHERUKUPALLI BHASKAR REDDY | Whole Time Director & COO | 2025 |
| Murali Sivaraman | Independent Non Exe. Director | 2025 |
| Madhavan Ganesan | Independent Non Exe. Director | 2025 |
| Aparna Surabhi | Independent Non Exe. Director | 2025 |
| Muralidharan Thyagarajanm | Independent Non Exe. Director | 2025 |
| Shrenik Soni | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 61 | 24 | 24 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-21 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 618 | 0 | 0 | 5 | 1 | 624 |
| 2025 | 11 | 0 | 0 | 0 | 0 | 11 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
2 recent disclosure(s)
Agilemed Investments Private LimitedRevoke · 41,71,970
Agilemed Investments Private LimitedPledge · 48,51,066
Substantial Acquisitions (SAST)
1 disclosure(s)
Pledge Released24/12/2025 · —
Company Information
Incorporated2006
ChairmanGANGADI MADHUKAR REDDY
AuditorB S R & Co
Investor Email[email protected]; [email protected]
📍 707 7th Floor 5-9-13 Saifabad, Taramandal Commercial Complex, Hyderabad, Telangana, 500004
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search